Researcher Profile Statistics: Wen Chin Chiang
Geo Map
Region
#
AS - Asia, other
15
NA - North America
3
EU - Europe
2
SA - South America
2
Unknown
8
Total
30
Country
#
SG - Singapore
15
US - United States of America
3
BR - Brazil
2
GB - United Kingdom
1
NL - Netherlands
1
Unknown
8
Total
30
City
#
Singapore
13
Buffalo
1
Immokalee
1
Irvine
1
Juazeiro do Norte
1
Naaldwijk
1
São Paulo
1
Unknown
11
Total
30
Bitstream
Downloads
ID: 1472903 - An Evaluation of the Mechanisms of Galacto-Oligosaccharide (GOS)-Induced IgE Cross-Linking on Basophils in GOS Allergy.pdf - ITEM:( 10635/230160)
14
Total: {0}
14
Most bitstream per type viewed
#
ID: other -
0
ID: journal -
16
ID: conference -
0
ID: patent -
0
ID: allItems -
0
ID: book -
0
ID: dataset -
0
ID: selected -
0
Total
16
Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
Tot
2022
0 0
0 0 0 13
2 1 0 1
1 1
19
2023
3 0
1 1 0 1
0 0 1 1
1 0
9
2024
0 0
1 1 0 0
0 0 0 0
0 0
2
Ever
30
Geo Map
Region | # |
---|---|
AS - Asia, other | 15 |
NA - North America | 3 |
EU - Europe | 2 |
SA - South America | 2 |
Unknown | 8 |
Total | 30 |
Country | # |
---|---|
SG - Singapore | 15 |
US - United States of America | 3 |
BR - Brazil | 2 |
GB - United Kingdom | 1 |
NL - Netherlands | 1 |
Unknown | 8 |
Total | 30 |
City | # |
---|---|
Singapore | 13 |
Buffalo | 1 |
Immokalee | 1 |
Irvine | 1 |
Juazeiro do Norte | 1 |
Naaldwijk | 1 |
São Paulo | 1 |
Unknown | 11 |
Total | 30 |
Bitstream | Downloads |
---|---|
ID: 1472903 - An Evaluation of the Mechanisms of Galacto-Oligosaccharide (GOS)-Induced IgE Cross-Linking on Basophils in GOS Allergy.pdf - ITEM:( 10635/230160) | 14 |
Total: {0} | 14 |
Most bitstream per type viewed | # |
---|---|
ID: other - | 0 |
ID: journal - | 16 |
ID: conference - | 0 |
ID: patent - | 0 |
ID: allItems - | 0 |
ID: book - | 0 |
ID: dataset - | 0 |
ID: selected - | 0 |
Total | 16 |
Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Tot | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2022 | 0 | 0 | 0 | 0 | 0 | 13 | 2 | 1 | 0 | 1 | 1 | 1 | 19 |
2023 | 3 | 0 | 1 | 1 | 0 | 1 | 0 | 0 | 1 | 1 | 1 | 0 | 9 |
2024 | 0 | 0 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2 |
Ever | 30 |